Alvotech secures $100 million term loan facility

Go back to Alvotech secures $100 million term loan facility

Alvotech Secures Term Loan Facility of USD 100 Million

December 31, 2025 4:30 PM EST

USD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotechs R&D pipeline and global product launches through 2026Led by GoldenTree Asset Management

REYKJAVIK, ICELAND (December 31, 2025) Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity... More